Insiders Entero Therapeutics, Inc.

Equities

ENTO

US33749P4081

Market Closed - Nasdaq Other stock markets 21:30:00 14/06/2024 BST			5-day change	1st Jan Change
2.07 ^USD	-5.91%		-15.25%	-50.71%

05-20	Entero Therapeutics, Inc.(NasdaqCM:ENTO) added to NASDAQ Composite Index	CI
05-17	First Wave BioPharma, Inc. will Change its Name to Entero Therapeutics, Inc	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

First Wave Biopharma, Inc. Announces Management Changes	03-14	CI
First Wave Biopharma, Inc Announces Resignation from the Board of Directors	17/06/22	CI
First Wave BioPharma, Inc. Appoints David Hoffman as Member of the Board	29/04/22	CI
James Pennington Announces His Intention to Retire as Chief Medical Officer of First Wave BioPharma, Inc	06/04/22	CI
First Wave BioPharma Names Sarah Romano as Chief Financial Officer	01/03/22	MT
First Wave Biopharma, Inc. Appoints Brian Feagan, M.D., to Scientific Advisory Board	09/12/21	CI
Vern Lee Schramm Not to Stand for Re-Election as Director of First Wave BioPharma, Inc	09/11/21	CI
First Wave BioPharma Forms Steering Committee for Phase 2a PASSPORT Clinical Trial to Evaluate FW-ICI-AC in Cancer Patients with Immune Checkpoint Inhibitor-Associated Colitis	21/10/21	CI
AzurRx BioPharma : to Change Name to First Wave BioPharma, Trade Under 'FWBI' Ticker From Sept. 22	21/09/21	MT
AzurRx BioPharma, Inc. has Changed its Name to First Wave BioPharma, Inc	21/09/21	CI
AzurRx BioPharma, Inc. Announces WHO Publication of Adrulipase Alfa as International Nonproprietary Name for MS1819	17/08/21	CI
AzurRx BioPharma, Inc. Announces Appointment of Terry Coelho to Its Board of Directors	16/08/21	CI
AzurRx BioPharma, Inc. Announces Chairman Changes	24/02/21	CI
AzurRx BioPharma Announces Appointment to Scientific Advisory Board	21/10/20	CI
AzurRx BioPharma, Inc. Announces Resignation of Johan Spoor as Director	01/05/20	CI
AzurRx BioPharma, Inc. Appoints Gregory Oakes to the Board of Directors, Effective April 13, 2020	09/04/20	CI
AzurRx Biopharma, Inc. Appoints Daniel Schneiderman as Chief Financial Officer	03/01/20	CI
AzurRx BioPharma, Inc. Announces the Resignation of Maged Shenouda as Chief Financial Officer	01/11/19	CI
AzurRx BioPharma, Inc. Announces Executive Changes	10/10/19	CI
AzurRx Announces Appoints Dr. James Pennington as Chief Medical Officer	30/05/18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Entero Therapeutics, Inc.

Equities

ENTO

US33749P4081

Insiders

Filters